Merz Loses Bid To Block Viatris In Unified Patent Court
Merz has failed to persuade the Unified Patent Court to order a preliminary injunction barring rival Viatris Santé from infringing its supplementary patent protections for its multiple sclerosis treatment, marking the first...To view the full article, register now.
Already a subscriber? Click here to view full article